GLP-1

Research

Glucagon-Like Peptide-1 (native hormone)

Aliases
GLP-1 (7-36)
Administration
Not applicable — native hormone, not administered directly due to rapid degradation

Research and regulatory

Development stage

Extensively characterized endogenous hormone. Not itself a drug product due to its extremely short half-life — synthetic long-acting analogs (semaglutide, liraglutide, tirzepatide) are the approved drug forms.

Legal and regulatory

Native human hormone; not a marketed drug product itself.

Side effects

Not applicable as a drug; physiological levels regulate normal digestion